Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First‐Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase <scp>II</scp> Study
Authors
Jingni Zhu
Jiamin Shi (ORCID: https://orcid.org/0000-0001-9966-4023)
Fei Yan (ORCID: https://orcid.org/0000-0002-8381-109X)
Delin Liu (ORCID: https://orcid.org/0000-0002-4451-2652)
Xiaoyou Li (ORCID: https://orcid.org/0000-0002-0307-3534)
Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First‐Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Study
Jingni Zhu, Jiamin Shi, Fei Yan, Delin Liu et al.
Citations
3 citations
Journal
Thoracic Cancer
Topics
Esophageal Cancer Research and Treatment
Field-Weighted Citation Impact (FWCI)
6.02
article
Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First‐Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Study